Lu AF90103

N/A

Report date: 2025/11/27 15:48:13

NME

Base Information

Drug NameLu AF90103

Drug Alias NameLu-AF-90103

ClassificationSmall molecules > Heterocyclic drugsSmall molecules > Prodrug

Mechanisms of ActionPositron-emission tomography enhancersGlutamate receptor ionotropic, NMDA 1/Glutamate [NMDA] receptor subunit epsilon 2 complex partial agonists

TargetsGlutamate receptor ionotropic, NMDA 1/Glutamate [NMDA] receptor subunit epsilon 2 complex

Therapy Area/IndicationsN/A

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySwedenNetherlands

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesH. Lundbeck A/S

China Registration ClassN/A

Develop Information

Active CompaniesH. Lundbeck A/S

Inactive CompaniesN/A

Active IndicationsN/A

Inactive IndicationsN/A

Other Information

ATC CodeN/A